GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Integra LifeSciences
Integra LifeSciences produces medical devices for neurosurgery and regenerative medicine. Its stock price is driven by the number of surgical procedures performed and innovations in wound treatment and tissue repair.
Share prices of companies in the market segment - Specialized medical equipment
Integra LifeSciences produces medical devices for neurosurgery and regenerative medicine. Its segments are Codman Specialty Surgical and Tissue Technologies. We classify it as part of the Specialized Medical Equipment sector, and the chart below reflects the dynamics of the entire medical technology industry.
Broad Market Index - GURU.Markets
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and surgical instruments. It is a component of the GURU.Markets index. The chart below shows the market. See how Integra shares compare to the healthcare sector.
Change in the price of a company, segment, and market as a whole per day
IART - Daily change in the company's share price Integra LifeSciences
The daily price change of Integra LifeSciences, a manufacturer of surgical medical devices, reflects the state of the healthcare system. Change_co shows sensitivity to innovation and hospital demand. This metric is important for analyzing the medical technology sector on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Integra LifeSciences Holdings Corporation is a medical device manufacturer. This chart shows the average daily volatility of the MedTech sector. Comparing it to IART, which focuses on neurosurgery and regenerative medicine, helps understand its unique risk profile.
Daily change in the price of a broad market stock, index - GURU.Markets
Integra LifeSciences is a manufacturer of medical devices for neurosurgery and regenerative medicine. The medical technology market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Integra's stock is responding to innovation.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Integra LifeSciences
Integra is a diversified medical device manufacturer. Its year-over-year performance provides a broad snapshot of key healthcare sectors. The chart shows how its strategy for niche markets creates stable shareholder value.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Integra LifeSciences Holdings Corporation is a leading medical technology company specializing in neurosurgery and regenerative medicine. This chart illustrates how its innovative products and diversified portfolio contribute to its robust growth in the healthcare sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Integra LifeSciences, a manufacturer of medical implants and instruments, operates in the defense sector. Demand for its products is driven by medical needs, not the state of the economy. The company's stock performance reflects its success in innovation and sales, making it a non-cyclical growth story.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Integra LifeSciences
The value of Integra, a medical device manufacturer, depends on the volume of elective surgeries. The monthly fluctuations on the chart reflect demand for its neurosurgery and regenerative medicine products, which is relatively stable but can be affected by the workload of healthcare systems.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Integra LifeSciences develops and manufactures innovative solutions for regenerative medicine, neurosurgery, and surgical instruments. The company's growth is driven by the clinical implementation of its technologies. The chart for the specialized medical equipment sector will show overall investor interest in this area and allow us to assess Integra's competitive position.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Medical device stocks can be more stable than the market due to non-cyclical demand. The chart below shows the overall fluctuations. Does Integra LifeSciences exhibit these defensive qualities, or does its reliance on elective surgeries make it vulnerable to economic downturns?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Integra LifeSciences
Integra LifeSciences, a manufacturer of medical devices for neurosurgery and regenerative medicine, whose weekly stock price reflects the volume of elective surgeries. New product news and the competitive environment shape short-term trends in this high-tech medical sector.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Integra LifeSciences, like other companies in the medical technology sector, reflects general trends. The chart compares its performance with the industry to show how much its growth is driven by the general trend toward surgical innovation, which is driving the entire sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Integra LifeSciences is a manufacturer of medical devices for surgery and regenerative medicine. Demand for its products is stable. The chart will show whether IART shares act as a safe haven, demonstrating less volatility than the market due to the consistent demand for medical services.
Market capitalization of the company, segment and market as a whole
IART - Market capitalization of the company Integra LifeSciences
Integra LifeSciences' market capitalization is a financial roadmap for regenerative medicine and neurosurgery. The company's performance, which produces implants for skin, bone, and brain tissue restoration, reflects the demand for sophisticated medical technologies. Its performance is a barometer of surgical innovations that help patients recover from severe injuries and surgeries.
IART - Share of the company's market capitalization Integra LifeSciences within the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in regenerative medicine and neurosurgery. The company produces implants and medical instruments for the treatment of complex wounds and tissue repair. Its market share reflects its technological leadership in these specialized areas. The chart below shows its market share in the high-tech medical market.
Market capitalization of the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in regenerative medicine, neurosurgery, and surgical instruments. The chart below shows the overall market capitalization of the entire medical device sector. Its growth reflects innovation and the ongoing need for new treatments.
Market capitalization of all companies included in a broad market index - GURU.Markets
Integra LifeSciences is a global leader in medical technologies for regenerative medicine, neurosurgery, and soft tissue surgery. Its market capitalization chart tells the story of human regeneration, demonstrating how innovative implants and instruments create value in healthcare.
Book value capitalization of the company, segment and market as a whole
IART - Book value capitalization of the company Integra LifeSciences
Integra LifeSciences' book value is derived from its factories producing complex medical implants and instruments. The chart below shows how the company manages its manufacturing base. Its growth reflects investments in neurosurgery and regenerative medicine technologies.
IART - Share of the company's book capitalization Integra LifeSciences within the market segment - Specialized medical equipment
Integra LifeSciences is a manufacturer of medical technologies for surgery and regenerative medicine. The company operates a network of specialized manufacturing facilities to produce its products. The asset share chart shows the company's control over the global manufacturing base for complex medical devices.
Market segment balance sheet capitalization - Specialized medical equipment
Integra LifeSciences produces a wide range of medical devices for surgery and neurosurgery. The development of these products requires certified manufacturing facilities and R&D centers. The book value chart shows how investments in these tangible assets form the foundation for medical innovation.
Book value of all companies included in the broad market index - GURU.Markets
Integra LifeSciences' assets are a manufacturing base for complex medical technologies. The company's book value reflects its plants producing neurosurgical implants, tissue regeneration, and surgical instruments. This represents tangible capital invested in creating products for the most critical areas of medicine.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Integra LifeSciences
Integra LifeSciences produces specialized medical instruments and implants for neurosurgery and regenerative medicine. Its balance sheet reflects its production capacity. Its market capitalization reflects a premium for its patents, strong positions in niche markets, and reputation among surgeons.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Integra LifeSciences produces medical devices for neurosurgery and regenerative medicine. The company combines R&D and manufacturing. The chart shows the market premium paid for its patents and leadership in niche medical fields over the value of its manufacturing facilities.
Market to book capitalization ratio for the market as a whole
Integra LifeSciences produces medical devices for neurosurgery and regenerative medicine. The company combines scientific development (patents) and manufacturing (factories). Its valuation is a balance between innovation and business stability. The chart shows how the market values this diversified player in the medical technology sector.
Debts of the company, segment and market as a whole
IART - Company debts Integra LifeSciences
Integra LifeSciences, a manufacturer of medical devices for neurosurgery and regenerative medicine, uses debt to fund research and acquisitions. This chart shows how the company invests in new product development and acquires companies with innovative technologies to strengthen its position in the specialized medical equipment market.
Market segment debts - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. In the MedTech sector, debt is often used to finance strategic acquisitions to acquire new technologies or enter adjacent markets. The chart shows how Integra's debt policy supports its growth strategy.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Integra LifeSciences
Integra LifeSciences develops and markets medical instruments and implants for neurosurgery and regenerative medicine. Growth in this field requires investment in R&D and complex regulatory processes. This chart shows how the company funds its innovations and potential acquisitions, and how this impacts its ability to compete in the medical device market.
Market segment debt to market segment book capitalization - Specialized medical equipment
Integra LifeSciences is a global leader in medical technologies for neurosurgery and regenerative medicine. This sector requires constant innovation and clinical research. This chart shows the overall debt burden in the industry. It helps understand how Integra finances its R&D and M&A transactions to maintain its technological leadership.
Debt to book value of all companies in the market
Integra LifeSciences, focusing on neurosurgery, is in the defensive sector. This chart shows the overall debt load of the economy. It helps assess the extent to which the company's business is independent of macroeconomic cycles. Demand for its products is driven by medical needs, not the state of the economy, making its business stable.
P/E of the company, segment and market as a whole
P/E - Integra LifeSciences
Integra LifeSciences produces medical devices for neurosurgery, regenerative medicine, and soft tissue surgery. This chart reflects demand for specialized medical technologies. Its dynamics show how investors evaluate the company's product innovation, its ability to obtain regulatory approval, and its leadership in its niches.
P/E of the market segment - Specialized medical equipment
Integra LifeSciences is in the medical device sector. This chart shows the average P/E for this innovative industry. A company's P/E is higher than the industry average, indicating that investors highly value its neurosurgery and regenerative medicine product portfolio, expecting it to grow faster than the average medical device manufacturer.
P/E of the market as a whole
Integra LifeSciences develops and markets medical instruments and implants for neurosurgery and regenerative medicine. The company's growth depends on innovation and the acceptance of its products by surgeons. This chart reflects sentiment in the healthcare sector. It helps understand whether Integra is a leader in its niches and how its valuation reflects the potential of new technologies to improve treatment outcomes.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery, regenerative medicine, and surgical instruments. This chart shows expected demand for specialized medical equipment. Future revenue depends on demographic trends, innovation, and hospital procedures.
%20P%2FE%20Integra%20LifeSciences&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Integra-LifeSciences&v=1772547625959 "Chart of the company's future (projected) P/E Integra LifeSciences")
Future (projected) P/E of the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and surgical instruments. This chart compares the company's profitability expectations with its sector. It helps understand how investors view its product portfolio and ability to innovate in complex medical fields.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772547625980 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. Demand for their products depends on the volume of elective surgeries and hospital budgets. The overall economic climate, shown in this graph, influences the financial health of healthcare systems and their ability to invest in advanced technologies.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772547626119 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Integra LifeSciences
Integra LifeSciences is a company that develops and manufactures medical devices for neurosurgery and regenerative medicine. Its financial performance depends on the number of surgical procedures performed using its products and innovations in its product line. This chart shows how demographic trends and the introduction of new technologies in medicine influence the company's growth.
Profit of companies in the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, as well as neurosurgical and orthopedic equipment. This graph, showing overall sector profitability, reflects the demand for advanced medical solutions. Integra's innovative products, which help treat complex conditions, directly impact the industry's growth and profitability.
Overall market profit
Integra LifeSciences is a global leader in medical technologies for regenerative medicine, neurosurgery, and soft tissue surgery. The company offers innovative solutions for the treatment of complex diseases. Its growth is driven by demographic trends and the constant introduction of new technologies into clinical practice, making it less dependent on economic cycles.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. Future revenue projections in this chart depend on demand for its specialized implants and instruments. Analysts estimate the volume of surgical procedures and the introduction of the company's innovative products.
%20profit%20of%20the%20company%20Integra%20LifeSciences&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Integra-LifeSciences&v=1772547626239 "Graph of future (projected) profit of the company Integra LifeSciences")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and orthopedics. This chart shows overall profitability forecasts for the specialized medical equipment sector. It helps understand how the company's innovative product portfolio aligns with overall healthcare trends and expectations.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772547626423 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Integra LifeSciences is a global leader in medical technologies for regenerative medicine, neurosurgery, and surgery. Demand for its products is driven by the number of surgical procedures and the introduction of new technologies. This schedule is important because during periods of economic growth, hospitals have greater financial capacity to purchase advanced equipment and materials.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772547626539 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. This chart, plotting market capitalization against sales, reflects the value of its innovative products. It shows how investors view its diversified portfolio and ability to develop solutions to complex medical challenges.
P/S market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, offering solutions for regenerative medicine, neurosurgery, and surgical instruments. The company's products help treat patients in critical situations. This chart reflects the market's willingness to pay for revenue in the specialized medical equipment sector, demonstrating confidence in Integra's innovation.
P/S of the market as a whole
Integra LifeSciences Holdings Corporation is a global leader in medical technology, specializing in regenerative medicine, as well as neurosurgical and orthopedic instruments. This chart helps investors compare the diversified medical technology company's revenue valuation with general market multiples.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. This chart shows how the market values the company based on its projected future sales. It reflects expectations for demand for advanced surgical solutions and innovative tissue repair products.
%20P%2FS%20Integra%20LifeSciences&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Integra-LifeSciences&v=1772547626643 "The graph of the company's future (projected) P/S Integra LifeSciences")
Future (projected) P/S of the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and surgical instruments. The chart compares the company's estimated future sales to the sector. This estimate reflects investor expectations regarding the innovativeness of its products and demographic trends, such as an aging population.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772547626714 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. The company's growth is driven by an aging population and the development of new surgical solutions. This graph of investor expectations reflects their belief in the long-term and stable growth of the medical device sector.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772547626727 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Integra LifeSciences
This chart reflects the demand for Integra LifeSciences' advanced medical technologies. The company's revenue is generated by selling a wide range of neurosurgical and regenerative medicine products. Sales growth reflects the adoption of its innovative solutions in hospitals and operating rooms worldwide to improve patient outcomes.
Sales of companies in the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and surgical instrumentation. The company's products improve patient outcomes. This chart represents the total revenue of the entire medical device market, illustrating the scale of the industry in which Integra is an innovator.
Overall market sales
Integra LifeSciences Holdings produces specialized medical equipment for neurosurgery and regenerative medicine. Demand for its products depends on the number of surgical procedures performed and hospital budgets. This graph, illustrating overall economic health, influences the financial capacity of the healthcare system and patient willingness to undergo elective surgeries.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. The company's sales are driven by the number of surgical procedures performed and the adoption of its innovative products. This chart reflects analysts' forecasts for growth in the specialized medical equipment and neurosurgery market.
%20sales%20of%20the%20company%20Integra%20LifeSciences&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Integra-LifeSciences&v=1772547626841 "Schedule of future (projected) sales of the company Integra LifeSciences")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery, regenerative medicine, and surgical instruments. This chart segments projected sales by these key divisions, allowing analysts to assess which medical areas analysts expect to see the greatest growth.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772547626875 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
This graph, reflecting healthcare costs and the number of surgical procedures, is important for Integra LifeSciences. The company produces medical instruments and implants for neurosurgery and regenerative medicine. Demand for its products depends on the stable functioning of hospitals and their ability to perform elective surgeries.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772547626889 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Integra LifeSciences
Integra LifeSciences is a leading medical technology company specializing in neurosurgery, regenerative medicine, and complex surgical instrumentation. This chart demonstrates innovation-driven profitability. Profitability depends on the development and implementation of unique products that become the standard of care in their fields.
Market segment marginality - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and instrumentation. Profitability depends on innovation and the success of its specialized products. This chart shows the average profitability in the sector. It helps assess Integra's strength in its niche medical areas.
Market marginality as a whole
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. Demand for its products depends on hospital budgets and the number of surgeries performed. This dynamic, reflecting the overall economic situation, influences healthcare system funding, which determines the ability of hospitals to purchase cutting-edge equipment.
Employees in the company, segment and market as a whole
Number of employees in the company Integra LifeSciences
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. This chart shows the size of the global team engaged in research, manufacturing, and sales. The growth in the chart reflects the expansion of the product portfolio and geographic presence to meet the needs of surgeons.
Share of the company's employees Integra LifeSciences within the market segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine, neurosurgery, and instrumentation. This chart shows the company's share of the total specialized medical equipment market. This reflects its broad product portfolio and deep expertise in several complex surgical areas.
Number of employees in the market segment - Specialized medical equipment
Integra LifeSciences Holdings is a global leader in medical technology, specializing in neurosurgery and regenerative medicine. The chart illustrates employment in the specialized medical equipment sector. The growing number of engineers and clinicians in this field demonstrates a constant commitment to innovation and the development of new products for complex surgical procedures.
Number of employees in the market as a whole
Integra LifeSciences is a global leader in medical technologies for regenerative medicine, neurosurgery, and surgery. Their growth is driven by innovation and demographic trends. This overall employment graph has an indirect impact. For Integra, the aging population and the development of new products that expand their market are more important.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Integra LifeSciences (IART)
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. The company combines cutting-edge research with the production of complex medical devices. This metric reflects the balance between the high value of its patents and products and the extensive staff dedicated to their production and sales.
%20of%20the%20company%20Integra%20LifeSciences%20(IART)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Integra-LifeSciences-IART&v=1772547627209 "Chart of market capitalization per employee (in thousands of dollars) of the company Integra LifeSciences (IART)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Integra LifeSciences (IART) produces high-tech medical devices for neurosurgery and regenerative medicine (such as artificial skin). Their value lies in their patents and clinical reputation. This chart helps assess how the market values their medical technologies.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772547627386 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. The company's value is determined by its innovative products and intellectual property. The high employee rating reflects the research-intensive nature of the business, where every researcher and engineer contributes to the creation of cutting-edge medical solutions.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772547627563 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Integra LifeSciences (IART)
Integra LifeSciences produces a wide range of medical devices for neurosurgery, regenerative medicine (artificial skin), and surgical instruments. It is a diversified medical technology business. This chart shows the combined profitability of their R&D, manufacturing, and sales: how effectively their teams bring these complex medical products to market and sell them.
%20Chart%20Integra%20LifeSciences%20(IART)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Integra-LifeSciences-IART&v=1772547627616 "Company Profit Per Employee (in thousands of dollars) Chart Integra LifeSciences (IART)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Integra LifeSciences is a "medtech" company. They "produce" "high-tech" "implants" and "instruments" for "neurosurgery" and "regenerative" "medicine." This graph shows the benchmark for "Specialized Medical Equipment." In this "B2B R&D" sector, the benchmark is *high*. Profit per engineer is "generated" by "patents" for "complex," "high-margin" "products."
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772547627733 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Integra LifeSciences is a global medical technology company. They specialize in neurosurgery (instruments, implants) and tissue regeneration technologies (artificial skin). This company has complex R&D and manufacturing processes. This chart helps us understand how a high-tech medical device manufacturer, which requires engineers and scientists, compares in terms of staff efficiency.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772547627767 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Integra LifeSciences (IART)
Integra LifeSciences is a global leader in medical technology, specializing in regenerative medicine and neurosurgery. Revenue per employee reflects the value of its innovative products and the strength of its commercial team. The chart shows how the company sells its specialized implants and instruments to hospitals worldwide.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Integra-LifeSciences-IART&v=1772547627797 "Sales chart per company employee Integra LifeSciences (IART)")
Sales per employee in the market segment - Specialized medical equipment
Integra LifeSciences produces high-tech medical equipment, specializing in neurosurgery (instruments, implants) and regenerative medicine (artificial skin). This chart demonstrates the productivity of their R&D and manufacturing teams. It reflects their ability to create and market complex, high-margin medical devices.
Sales per employee for the market as a whole
Integra LifeSciences (IART) is a medical technology company specializing in regenerative medicine (e.g., artificial skin for burn treatment) and neurosurgery (instruments, implants). This chart reflects the efficiency of high-tech medical device production. Integra's products are not mass-produced goods, but rather complex, high-margin devices. The growth of this indicator indicates successful R&D.
Short shares by company, segment and market as a whole
Shares shorted by company Integra LifeSciences (IART)
Integra LifeSciences produces a wide range of medical devices for neurosurgery, regenerative medicine (artificial skin), and surgical instruments. This chart shows the level of skepticism. Skeptics may be concerned about recent product quality issues and recalls, which could damage the company's reputation and lead to a loss of market share, or they may fear a general slowdown in elective surgeries.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Integra-LifeSciences-IART&v=1772547628037 "Short Shares Chart for the Company Integra LifeSciences (IART)")
Shares shorted by market segment - Specialized medical equipment
Integra LifeSciences (IART) produces medical devices for neurosurgery and regenerative medicine (e.g., artificial skin). This chart shows bets against the specialized medical equipment sector. Short positions in this segment may reflect concerns about supply chain disruptions or a slowdown in the number of elective surgeries where their products are used.
Shares shorted by the overall market
Integra LifeSciences produces complex medical equipment for neurosurgery and regenerative medicine. Although healthcare is considered a defensive sector, IART's business depends on hospital capital budgets. When this chart shows rising fears, investors fear that hospitals will reduce their purchases of expensive equipment in a recession.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Integra LifeSciences (IART)
Integra LifeSciences produces medical devices for neurosurgery and regenerative medicine. Its business depends on hospital procedure volumes and expenses. A reading above 70 may reflect strong demand for procedures. A reading below 30 may reflect concerns about hospital budget cuts or product shortages.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Integra-LifeSciences-IART&v=1772547628321 "RSI 14 indicator chart for the company's stock Integra LifeSciences (IART)")
RSI 14 Market Segment - Specialized medical equipment
Integra LifeSciences is a global leader in medical technology, specializing in neurosurgery (skull implants, monitoring) and regenerative medicine (artificial skin). This chart tracks the collective sentiment in the specialized medical equipment sector. It helps assess how investors view the neurosurgery and regenerative technologies niche.
RSI 14 for the overall market
Integra LifeSciences (IART) produces neurosurgical implants. This chart shows that its business is "defensive." Demand for brain or spine surgeries isn't dependent on euphoria or panic—it's a matter of life and death. During moments of market panic, investors seek safe havens in companies with non-cyclical demand.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast IART (Integra LifeSciences)
Integra LifeSciences (IART) is a medical technology company. It is a global leader in neurosurgery (e.g., dura mater substitutes) and regenerative medicine (wound and burn treatment). This chart shows the average analyst forecast, reflecting their expectations for the volume of elective surgeries and the introduction of new products.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-IART-Integra-LifeSciences&v=1772547628553 "A chart showing analyst consensus forecasts for the expected stock price. IART (Integra LifeSciences)")
The difference between the consensus estimate and the actual stock price IART (Integra LifeSciences)
Integra LifeSciences (IART) is a medical technology company, a leader in two niches: neurosurgery (brain surgery equipment) and regenerative medicine (artificial skin). This chart shows the difference between the consensus forecast and the price. It reflects whether analysts believe the company will recover from its production problems.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-IART-Integra-LifeSciences&v=1772547628601 "A chart showing the difference between the consensus forecast and the actual stock price. IART (Integra LifeSciences)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Integra LifeSciences is a global leader in regenerative technologies. The company produces products for wound healing, tissue repair (skin, nerves), and neurosurgery. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the complex reconstructive surgery market will grow.
Analysts' consensus forecast for the overall market share price
Integra LifeSciences (IART) is a manufacturer of niche medical devices (neurosurgery, artificial skin). This chart of overall market sentiment is important. Optimism = hospitals are more willing to spend on premium, innovative procedures. During a recession (pessimism), investors value IART for its non-cyclical demand for emergency surgeries.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Integra LifeSciences
Integra LifeSciences (IART) is a MedTech company specializing in two areas: neurosurgery (equipment, monitoring) and regenerative medicine (artificial skin, implants). This chart summarizes their two niches. It reflects the stable demand for their neurosurgical instruments and the growth potential of their innovative regenerative products.
AKIMA Market Segment Index - Specialized medical equipment
Integra LifeSciences (IART) is a diversified medtech leader focused on two niches: Neurosurgery (equipment) and Regenerative Medicine (artificial skin, collagen). This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this hybrid (neuro + regenerative) model (IART) differentiate it from the average medtech competitor?
The AKIM Index for the overall market
Integra LifeSciences is a global leader in neurosurgery and regenerative technologies (skin, tissue). This chart, reflecting the market average, provides context. It helps assess how IART, a "defensive" business dependent on complex surgeries and supply recovery after quality issues, fares against the backdrop of overall macroeconomic fluctuations.
